Bonney Michael W
- SEC CIK
- 0001219016
No open-market purchases or sales filed in the past year.
Current role at each company
- AUTL Autolus Therapeutics plcDirectoras of Jul 1, 2026
- IMUX Immunic, Inc.Directoras of Jun 29, 2026
- ALNY Alnylam Pharmaceuticals, Inc.Directoras of Aug 19, 2025
- BMY Bristol Myers Squibb CoDirectoras of Jul 1, 2021
- KLDO Kaleido Biosciences, Inc.Directoras of Jul 1, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bonney Michael W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALNY Alnylam Pharmaceuticals, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2025 (view filing) | Aug 18 | 1 day | Bonney Michael WDirector | SSale | −11.3K | $450.00 | −$5.06M | −40.1%16.8K after | 10b5-1 |
| May 19, 2025 (view filing) | May 15 | 4 days | Bonney Michael WDirector | SSale | −11.3K | $277.71 | −$3.12M | −40.1%16.8K after | 14 lots10b5-1 |
| Dec 29, 2023 (view filing) | Dec 27 | 2 days | Bonney Michael WDirector | SSale | −30.0K | $195.00 | −$5.85M | −65.2%16.0K after | 10b5-1 |
| Aug 4, 2023 (view filing) | Aug 3 | 1 day | Bonney Michael WDirector | SSale | −6.45K | $185.38 | −$1.20M | −28.7%16.0K after | 7 lots |